Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Mette Yde Dam"'
Autor:
Cecilie Juul Hviid, Marianne Lund, Allan Sørensen, Svend Ellermann-Eriksen, Bente Jespersen, Mette Yde Dam, Jens Frederik Dahlerup, Thomas Benfield, Sanne Jespersen, Lars Jørgen Østergaard, Alex Lund Laursen, Bissau HIV cohort study group
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174012 (2017)
BACKGROUND:Diagnosis of Pneumocystis jirovecii (PJ) pneumonia ordinarily requires invasive procedures that could be avoided by PCR methodologies, if these could be designed with adequate cut-off values for confounding background carriage. METHODS:We
Externí odkaz:
https://doaj.org/article/798a9f0f43ca491683f1aa77693b80bf
Autor:
Kristian Stengaard-Pedersen, Torkell Ellingsen, Hanne Merete Lindegaard, Peter Junker, Anette Jørgensen, Julia S. Johansen, Lykke Midtbøll Ørnbjerg, Tine Lottenburger, Rebecca Bolce, Cecilie Heegaard Brahe, Asta Linauskas, X Wang, Nadine Defranoux, Eric H. Sasso, Palle Ahlquist, Johnny Lillelund Raun, Mikkel Østergaard, Sophine B. Krintel, Ib Hansen, Christian Gytz Ammitzbøll, Kim Hørslev-Petersen, Annette Schlemmer, Merete Lund Hetland, Mette Yde Dam
Publikováno v:
Brahe, C H, Østergaard, M, Johansen, J S, Defranoux, N, Wang, X, Bolce, R, Sasso, E, Ørnbjerg, L, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C, Jørgensen, A, Krintel, S, Raun, J & Hetland, M 2019, ' Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis : a post-hoc study of the OPERA trial ', Scandinavian Journal of Rheumatology, vol. 48, no. 1, pp. 9-16 . https://doi.org/10.1080/03009742.2018.1464206
Brahe, C H, Østergaard, M, Johansen, J S, Defranoux, N, Wang, X, Bolce, R, Sasso, E H, Ørnbjerg, L M, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C, Jørgensen, A, Krintel, S B, Raun, J & Hetland, M L 2019, ' Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis : a post-hoc study of the OPERA trial ', Scandinavian Journal of Rheumatology, vol. 48, no. 1, pp. 9-16 . https://doi.org/10.1080/03009742.2018.1464206
Brahe, C H, Østergaard, M, Johansen, J S, Defranoux, N, Wang, X, Bolce, R, Sasso, E H, Ørnbjerg, L M, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C, Jørgensen, A, Krintel, S B, Raun, J & Hetland, M L 2019, ' Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis : a post-hoc study of the OPERA trial ', Scandinavian Journal of Rheumatology, vol. 48, no. 1, pp. 9-16 . https://doi.org/10.1080/03009742.2018.1464206
OBJECTIVES: Measurement of serum biomarkers at disease onset may improve prediction of disease course in patients with early rheumatoid arthritis (RA). We evaluated the multi-biomarker disease activity (MBDA) score and early changes in MBDA score for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea3dba9f21c328597c172b320aec3e4d
https://pubmed.ncbi.nlm.nih.gov/29985080
https://pubmed.ncbi.nlm.nih.gov/29985080
Autor:
Peter Junker, Tove Lorenzen, Tonny Jensen, Mikkel Østergaard, Natalia Manilo, Henning Bliddal, Kristian Stengaard-Pedersen, Lykke Midtbøll Ørnbjerg, Tine Lottenburger, Marcin Ryszard Kowalski, Hans Christian Horn, Hanne Merete Lindegaard, I. Hansen, Ole Slot, Anette Jørgensen, Inger Lauge Johansen, Palle Ahlquist, Asta Linauskas, Annette Schlemmer, Lars Kjær Nielsen, Torkell Ellingsen, Peter Mosborg Pedersen, O Majgaard, Christian Gytz Ammitzbøll, Mette Yde Dam, Johnny Lillelund Raun, Merete Lund Hetland, Kim Hørslev-Petersen, Henrik Skjødt, Sophine B. Krintel
Publikováno v:
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, Slot, O, Nielsen, L K, Skjødt, H, Majgaard, O, Lorenzen, T, Horn, H C, Kowalski, M, Johansen, I L, Pedersen, P M, Manilo, N, Bliddal, H & OPERA Study Group 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781-789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group & Lorenzen, T 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781-789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group, Slot, O, Nielsen, L K, Skjødt, H, Majgaard, O, Lorenzen, T, Horn, H C, Kowalski, M, Johansen, I L, Pedersen, P M, Manilo, N & Bliddal, H 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab : a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781–789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group & Lorenzen, T 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781-789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group, Slot, O, Nielsen, L K, Skjødt, H, Majgaard, O, Lorenzen, T, Horn, H C, Kowalski, M, Johansen, I L, Pedersen, P M, Manilo, N & Bliddal, H 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab : a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781–789 . https://doi.org/10.1007/s10067-016-3489-1
This study aims to investigate 1-year hand bone loss (HBL 1-year) in early rheumatoid arthritis (RA) patients treated with a methotrexate (MTX) and intra-articular triamcinolone treat-to-target strategy +/− adalimumab and to determine if HBL 6month
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1278219bd037cb38835e551f2c6113
https://vbn.aau.dk/da/publications/5f92c4a2-ba8f-4497-bb5f-3f87c3f31dd4
https://vbn.aau.dk/da/publications/5f92c4a2-ba8f-4497-bb5f-3f87c3f31dd4
Autor:
Mikkel Østergaard, Peter Junker, Hans Christian Horn, Asta Linauskas, Ib Tønder Hansen, Mette Bjørndal Axelsen, Palle Ahlquist, Hanne Merete Lindegaard, Julia S. Johansen, Niels Steen Krogh, Merete Lund Hetland, Iris Eshed, Johnny Lillelund Raun, Sophine B. Krintel, Jan Pødenphant, Mette Yde Dam, Kim Hørslev-Petersen, Kristian Stengaard-Pedersen, Anette Jørgensen, Christian Gytz Ammitzbøll, J. Møller, Torkell Ellingsen, Annette Schlemmer
Publikováno v:
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J, Junker, P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Ostergaard, M & OPERA study group 2015, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis : Results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 867-875 . https://doi.org/10.1136/annrheumdis-2013-204537
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J, Junker, M P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Østergaard, M & OPERA Study Group 2014, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis : results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2013-204537
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J R, Junker, P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I T, Horn, H C, Ammitzbøll, C G, Jørgensen, A J, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Ostergaard, M & OPERA Study Group 2015, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 867-875 . https://doi.org/10.1136/annrheumdis-2013-204537
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J, Junker, M P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Østergaard, M & OPERA Study Group 2014, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis : results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2013-204537
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J R, Junker, P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I T, Horn, H C, Ammitzbøll, C G, Jørgensen, A J, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Ostergaard, M & OPERA Study Group 2015, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 867-875 . https://doi.org/10.1136/annrheumdis-2013-204537
OBJECTIVES: To investigate whether a treat-to-target strategy with methotrexate and intra-articular glucocorticosteroid injections suppresses MRI inflammation and halts structural damage progression in patients with early rheumatoid arthritis (ERA),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21c0fb21d4b5dc46f7a4d94759490741
https://doi.org/10.1136/annrheumdis-2013-204537
https://doi.org/10.1136/annrheumdis-2013-204537
Autor:
Ib Tønder Hansen, Kristian Stengaard-Pedersen, Julia S. Johansen, Peter Junker, Hanne Merete Lindegaard, Mikkel Østergaard, Torkell Ellingsen, Anette Jørgensen, Merete Lund Hetland, Hans Christian Horn, Sophine B. Krintel, Johnny Lillelund Raun, Mette Yde Dam, Christian Gytz Ammitzbøll, Palle Ahlquist, Annette Schlemmer, Jan Pødenphant, Opera study-group, Asta Linauskas, Kim Hørslev-Petersen
Publikováno v:
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Ostergaard, M, Stengaard-Pedersen, K & OPERA study-group 2014, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study : An investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases, vol. 73, no. 4, pp. 654-661 . https://doi.org/10.1136/annrheumdis-2012-202735
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Tønder Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2013, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study : an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2012-202735
OPERA Study Group 2014, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life : The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases, vol. 73, no. 4, pp. 654-661 . https://doi.org/10.1136/annrheumdis-2012-202735
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Tønder Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2013, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study : an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2012-202735
OPERA Study Group 2014, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life : The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases, vol. 73, no. 4, pp. 654-661 . https://doi.org/10.1136/annrheumdis-2012-202735
OBJECTIVES: An investigator-initiated, double-blinded, placebo-controlled, treat-to-target protocol (Clinical Trials:NCT00660647) studied whether adalimumab added to methotrexate and intra-articular triamcinolone as first-line treatment in early rheu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e10e52e936fd7f22b860f244fa2336f
https://doi.org/10.1136/annrheumdis-2012-202735
https://doi.org/10.1136/annrheumdis-2012-202735
Autor:
Hanne Merete Lindegaard, Johnny Lillelund Raun, Inger Marie Jensen Hansen, Peter Junker, Merete Lund Hetland, Torkell Ellingsen, Kim Hørslev-Petersen, S B Krintel, Christian Gytz Ammitzbøll, Palle Ahlquist, Kristian Stengaard-Pedersen, Annette Schlemmer, Asta Linauskas, Julia S. Johansen, Jan Pødenphant, Opera study-group, Lykke Midtbøll Ørnbjerg, Tine Lottenburger, Anette Jørgensen, Mikkel Østergaard, Mette Yde Dam
Publikováno v:
Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study-Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I T, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I T, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
ObjectivesTo study clinical and radiographic outcomes after withdrawing 1 year's adalimumab induction therapy for early rheumatoid arthritis (eRA) added to a methotrexate and intra-articular triamcinolone hexacetonide treat-to-target strategy (NCT006
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac2d7af6f3aa2b382362ad99b1a826d9
https://vbn.aau.dk/da/publications/cbe84af7-b9ff-46d8-be4f-4290c472866c
https://vbn.aau.dk/da/publications/cbe84af7-b9ff-46d8-be4f-4290c472866c
Autor:
Johnny Lillelund Raun, Lars Erik Kristensen, Michael Sejer Hansen, Hanne Merete Lindegaard, Inger Marie Jensen Hansen, Vibeke Sørensen, Tove Lorenzen, Jørgen Juncher Jensen, Merete Lund Hetland, Anita Kincses, Sheraz Butt, Mikkel Østergaard, T. Laursen, Robin Christensen, Oliver Hendricks, Jolanta Grydehøj, Henning Bliddal, Niels Steen Krogh, Marlene Andersen, Jakob Espesen, Tanja Schjødt Jørgensen, L. Larsen, Prabhat Kumar, D V Jensen, Esben K Næser, Barbara Unger, Lida Zanjani, Sara Vildhøj, Mette Yde Dam, Ninna Dufour
Publikováno v:
Jørgensen, T S, Kristensen, L E, Christensen, R, Bliddal, H, Lorenzen, T, Hansen, M S, Østergaard, M, Jensen, J, Zanjani, L, Laursen, T, Butt, S, Dam, M Y, Lindegaard, H M, Espesen, J, Hendricks, O, Kumar, P, Kincses, A, Larsen, L H, Andersen, M, Næser, E K, Jensen, D V, Grydehøj, J, Unger, B, Dufour, N, Sørensen, V, Vildhøj, S, Jensen Hansen, I M, Raun, J, Krogh, N S & Lund Hetland, M 2015, ' Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis : a cohort study of patients registered in the Danish biologics registry ', Rheumatology, vol. 54, no. 12, pp. 2156-65 . https://doi.org/10.1093/rheumatology/kev216
Jørgensen, T S, Kristensen, L E, Christensen, R, Bliddal, H, Lorenzen, T, Hansen, M S, Østergaard, M, Jensen, J, Zanjani, L, Laursen, T, Butt, S, Dam, M Y, Lindegaard, H M, Espesen, J, Hendricks, O, Kumar, P, Kincses, A, Larsen, L H, Andersen, M, Næser, E K, Jensen, D V, Grydehøj, J, Unger, B, Dufour, N, Sørensen, V, Vildhøj, S, Jensen Hansen, I M, Raun, J, Krogh, N S & Lund Hetland, M 2015, ' Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis : a cohort study of patients registered in the Danish biologics registry ', Rheumatology, vol. 54, no. 12, pp. 2156-2165 . https://doi.org/10.1093/rheumatology/kev216
Jørgensen, T S, Kristensen, L E, Christensen, R, Bliddal, H, Lorenzen, T, Hansen, M S, Østergaard, M, Jensen, J, Zanjani, L, Laursen, T, Butt, S, Dam, M Y, Lindegaard, H M, Espesen, J, Hendricks, O, Kumar, P, Kincses, A, Larsen, L H, Andersen, M, Næser, E K, Jensen, D V, Grydehøj, J, Unger, B, Dufour, N, Sørensen, V, Vildhøj, S, Jensen Hansen, I M, Raun, J, Krogh, N S & Lund Hetland, M 2015, ' Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis : a cohort study of patients registered in the Danish biologics registry ', Rheumatology, vol. 54, no. 12, pp. 2156-2165 . https://doi.org/10.1093/rheumatology/kev216
OBJECTIVES: To estimate the prevalence of Danish RA patients currently on biologic monotherapy and compare the effectiveness and drug adherence of biologic therapies applied as monotherapy.METHODS: All RA patients registered in the Danish biologics d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::683e286aae88bc418ffb922584665fe4
https://pure.au.dk/portal/da/publications/effectiveness-and-drug-adherence-of-biologic-monotherapy-in-routine-care-of-patients-with-rheumatoid-arthritis(f3bc0c09-383c-4c26-9a28-027fc5bd976f).html
https://pure.au.dk/portal/da/publications/effectiveness-and-drug-adherence-of-biologic-monotherapy-in-routine-care-of-patients-with-rheumatoid-arthritis(f3bc0c09-383c-4c26-9a28-027fc5bd976f).html
Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool
Autor:
Allan Sørensen, Mette Yde Dam, Jens Frederik Dahlerup, Cecilie Juul Hviid, Bente Jespersen, Svend Ellermann Eriksen, Thomas Benfield, Sanne Jespersen, Alex Lund Laursen, Marianne Lund, Lars Østergaard
Publikováno v:
Hviid, C J, Ellermann-Eriksen, S, Jespersen, B, Dam, M Y, Dahlerup, J F, Benfield, T, Jespersen, S, Østergaard, L J & Laursen, A L 2017, ' Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool ', PLOS ONE, vol. 12, no. 3, e0174012 . https://doi.org/10.1371/journal.pone.0174012
PLoS ONE, Vol 12, Iss 3, p e0174012 (2017)
PLoS ONE
Hviid, C J, Lund, M, Sørensen, A, Ellermann-Eriksen, S, Jespersen, B, Dam, M Y, Dahlerup, J F, Benfield, T, Jespersen, S, Østergaard, L J, Laursen, A L & Bissau HIV Cohort Study Group 2017, ' Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool ', P L o S One, vol. 12, no. 3, e0174012 . https://doi.org/10.1371/journal.pone.0174012
PLoS ONE, Vol 12, Iss 3, p e0174012 (2017)
PLoS ONE
Hviid, C J, Lund, M, Sørensen, A, Ellermann-Eriksen, S, Jespersen, B, Dam, M Y, Dahlerup, J F, Benfield, T, Jespersen, S, Østergaard, L J, Laursen, A L & Bissau HIV Cohort Study Group 2017, ' Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool ', P L o S One, vol. 12, no. 3, e0174012 . https://doi.org/10.1371/journal.pone.0174012
BACKGROUND: Diagnosis of Pneumocystis jirovecii (PJ) pneumonia ordinarily requires invasive procedures that could be avoided by PCR methodologies, if these could be designed with adequate cut-off values for confounding background carriage.METHODS: We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae530659b9aefbbc6568272a9f03265b
https://doi.org/10.1371/journal.pone.0174012
https://doi.org/10.1371/journal.pone.0174012
Autor:
Christian Gytz Ammitzbøll, Kristian Stengaard-Pedersen, Merete Lund Hetland, Peter Junker, Mikkel Østergaard, Klaus Kaae Andersen, Torkell Ellingsen, Christian Dehlendorff, Hans Christian Horn, Annette Schlemmer, Mette Yde Dam, Palle Ahlquist, Johnny Lillelund Raun, Anette Jørgensen, Kim Hørslev-Petersen, J.S. Johansen, Sophine B. Krintel, Asta Linauskas, Jan Pødenphant, Hanne Merete Lindegaard, I. Hansen
Publikováno v:
Krintel, S B, Dehlendorff, C, Hetland, M L, Hørslev-Petersen, K, Andersen, K K, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Horn, H C, Jørgensen, A, Raun, J, Ammitzbøll, C G, Østergaard, M, Stengaard-Pedersen, K & Johansen, J S 2016, ' Prediction of treatment response to adalimumab : a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis ', Pharmacogenomics Journal, vol. 16, no. 2, pp. 141-146 . https://doi.org/10.1038/tpj.2015.30
Krintel, S B, Dehlendorff, C, Hetland, M L, Hørslev-Petersen, K, Andersen, K K, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, MY, Hansen, I, Horn, H C, Jørgensen, A, Raun, J, Ammitzbøll, C G, Østergaard, M, Stengaard-Pedersen, K & Johansen, J S 2016, ' Prediction of treatment response to adalimumab : a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis ', Pharmacogenomics Journal, vol. 16, no. 2, pp. 141-6 . https://doi.org/10.1038/tpj.2015.30
Krintel, S B, Dehlendorff, C, Hetland, M L, Hørslev-Petersen, K, Andersen, K K, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Horn, H C, Jørgensen, A, Raun, J, Ammitzbøll, C G, Østergaard, M, Stengaard-Pedersen, K & Johansen, J S 2016, ' Prediction of treatment response to adalimumab : a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis ', The Pharmacogenomics Journal, vol. 16, no. 2, pp. 141–146 . https://doi.org/10.1038/tpj.2015.30
Krintel, S B, Dehlendorff, C, Hetland, M L, Hørslev-Petersen, K, Andersen, K K, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, MY, Hansen, I, Horn, H C, Jørgensen, A, Raun, J, Ammitzbøll, C G, Østergaard, M, Stengaard-Pedersen, K & Johansen, J S 2016, ' Prediction of treatment response to adalimumab : a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis ', Pharmacogenomics Journal, vol. 16, no. 2, pp. 141-6 . https://doi.org/10.1038/tpj.2015.30
Krintel, S B, Dehlendorff, C, Hetland, M L, Hørslev-Petersen, K, Andersen, K K, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Horn, H C, Jørgensen, A, Raun, J, Ammitzbøll, C G, Østergaard, M, Stengaard-Pedersen, K & Johansen, J S 2016, ' Prediction of treatment response to adalimumab : a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis ', The Pharmacogenomics Journal, vol. 16, no. 2, pp. 141–146 . https://doi.org/10.1038/tpj.2015.30
At least 30% of patients with rheumatoid arthritis (RA) do not respond to biologic agents, which emphasizes the need of predictive biomarkers. We aimed to identify microRNAs (miRNAs) predictive of response to adalimumab in 180 treatment-naïve RA pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60db69177199293d3152077ddf142c70
https://pubmed.ncbi.nlm.nih.gov/25939484
https://pubmed.ncbi.nlm.nih.gov/25939484
Autor:
C. G. Ammitzbøll, Merete Lund Hetland, Kim Hørslev-Petersen, Mette Yde Dam, Kristian Stengaard-Pedersen, Peter Junker, Eric H. Sasso, J. Johansen, Nadine Defranoux, SB Krintel, Inger Marie Jensen Hansen, J Raun, Palle Ahlquist, Mikkel Østergaard, Hanne Merete Lindegaard, Annette Schlemmer, A. Jørgensen, Rebecca Bolce, C.C. Hwang, C. H. Brahe, Asta Linauskas, T. Lottenburger, Torkell Ellingsen
Publikováno v:
Annals of the Rheumatic Diseases. 75:450.1-450
Background No single biomarker has yet been able to predict disease course in patients with rheumatoid arthritis (RA). However combinations of biomarkers and changes therein early during treatment may be predictive of later treatment response. Object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bc5b9d849981df929f9096ca64479af
https://doi.org/10.1136/annrheumdis-2016-eular.3459
https://doi.org/10.1136/annrheumdis-2016-eular.3459